Yen Hui Huang in Cape Girardeau, Missouri

Medical School: Sorry, his university is not listed
Graduation Year: 2000
The Primary Medical Specialty for Yen Hui Huang is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 24
PAC (PECOS ID)#: 8527332725
NPI #: 1164696779
NPI Created On: 04/15/2008
NPI Last Updated Listed as: 09/10/2020
Primary Taxonomy Code: 207R00000X
License Number:
42050
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Chinese.

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
3. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
4. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
6. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
7. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
8. Follow-up or limited ultrasound examination of heart
9. New patient office or other outpatient visit, typically 45 minutes
10. New patient office or other outpatient visit, typically 45 minutes
11. Established patient office or other outpatient visit, typically 15 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Hospital observation care, typically 50 minutes
14. Initial hospital inpatient care, typically 50 minutes per day
15. Subsequent hospital inpatient care, typically 25 minutes per day
16. Subsequent hospital inpatient care, typically 35 minutes per day
17. Technetium tc-99m tetrofosmin, diagnostic, per study dose
18. Injection, regadenoson, 0.1 mg